nilvadipine has been researched along with Carotid Artery Narrowing in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of a calcium antagonist, nilvadipine, on cerebral blood flow and oxygen metabolism, we prospectively examined five ischaemic stroke patients, with both hypertension and chronic major cerebral artery occlusion, using positron emission tomography." | 5.10 | Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study. ( Kobayashi, M; Noda, A; Ogasawara, K; Ogawa, A; Yasuda, S; Yukawa, H, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogasawara, K | 1 |
| Noda, A | 1 |
| Yasuda, S | 1 |
| Kobayashi, M | 1 |
| Yukawa, H | 1 |
| Ogawa, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A European Multicentre Double-blind Placebo-controlled Phase III Trial of Nilvadipine in Mild to Moderate Alzheimer's Disease[NCT02017340] | Phase 3 | 511 participants (Actual) | Interventional | 2013-04-24 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nilvadipine and Carotid Artery Narrowing
| Article | Year |
|---|---|
Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Carotid Stenosis; Cerebrovascular Circulation; Femal | 2003 |